JATENZO is the first and only FDA-approved oral softgel for testosterone (T) replacement therapy in adult males who have deficient T due to certain medical conditions Clarus expects to announce results from the trial in […]
Broadened strategic focus and expanded pipeline in immunology and inflammation following acquisition of rights to BBI-02, a potential first-in-class oral DYRK1A inhibitor, a portfolio of novel STING inhibitors, and a next-generation kinase inhibitor platform On […]
Interim results show that oral cepharanthine plus cabazitaxel (combination therapy) significantly reduced tumor volume and increased tumor growth inhibition at day 21, the final day of dosing Dose range findings demonstrate that oral cepharanthine-alone was […]
SALT LAKE CITY, Feb. 17, 2022 / — PolarityTE, Inc. (NASDAQ: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S. Application […]
HAMILTON, Ontario, Feb. 15, 2022 — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare […]
HAMILTON, Ontario, Feb. 09, 2022 — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare […]
Reliq Health Technologies (TSX.V: RHT) (OTC: RQHTF) NEXT SUPER STOCK livestream 1/27/2022 Reliq Health Technologies (TSX.V: RHT) (OTC: RQHTF) NEXT SUPER STOCK livestream 1/5/2022 Reliq Health Technologies (TSX.V: RHT) (OTC: RQHTF) NEXT SUPER STOCK live! […]
Reliq Health Technologies (TSX.V: RHT) (OTC: RQHTF) NEXT SUPER STOCK livestream 1/5/2022 Reliq Health Technologies (TSX.V: RHT) (OTC: RQHTF) NEXT SUPER STOCK live! 9/9/2021 Reliq Health Technologies (TSX.V: RHT) (OTC: RQHTF) NEXT SUPER STOCK live! […]
Product roll out and pilot studies planned for the fourth quarter 2021 TORONTO, ON / September 28, 2021 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address […]
TORONTO, ON /September 9, 2021 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIML)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its majority-owned subsidiary, Health Gauge […]
TORONTO, ON /September 7, 2021 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its majority-owned subsidiary, Health Gauge […]
SAA Report endorsed Tetra Bio-Pharma’s proposed nonclinical development and quality programs for QIXLEEF™. SAA Report provides clarity on clinical requirements for registration in Europe. OTTAWA, ON, Sept. 2, 2021 – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: […]
HAMILTON, Ontario, Sept. 01, 2021– Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today […]
TORONTO, ON / August 30, 2021 / AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to introduce its newest subsidiary, AI Rx […]
Teladoc Health, Inc. (NYSE: TDOC) Q2 2021 Earnings Highlights Jason Gorevic, CEO “…The broad-based strength across our portfolio drove revenue of $503 million in the second quarter, an increase of 109% over the prior year, […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
